Impact of the pandemic and concomitant COVID-19 on the management and outcomes of middle cerebral artery strokes : a nationwide registry-based study
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
OBJECTIVES: To investigate the impact of the COVID-19 pandemic as well as concomitant COVID-19 itself on stroke care, focusing on middle cerebral artery (MCA) territory infarctions.
DESIGN: Registry-based study.
SETTING: We used the National Inpatient Sample (NIS) database, which covers a wide range of hospitals within the USA.
PARTICIPANTS: The NIS was queried for patients with MCA strokes between 2016 and 2020. In total, 35 231 patients were included.
OUTCOME MEASURES: Outcome measures were postprocedural complications, length of stays (LOSs), in-hospital mortality and non-routine discharge. Propensity score matching using all available baseline variables was performed to reduce confounders when comparing patients with and without concomitant COVID-19.
RESULTS: Mechanical thrombectomy (MT) was performed in 48.4%, intravenous thrombolysis (IVT) in 38.2%, and both MT and IVT (MT+IVT) in 13.4% of patients. A gradual increase in the use of MT and an opposite decrease in the use of IVT (p<0.001) was detected during the study period. Overall, 25.0% of all patients were admitted for MCA strokes during the pandemic period (2020), of these 209 (2.4%) were concomitantly diagnosed with COVID-19. Patients with MCA strokes and concomitant COVID-19 were significantly younger (64.9 vs 70.0; p<0.001), had significantly worse NIH Stroke Severity scores, and worse outcomes in terms of LOS (12.3 vs 8.2; p<0.001), in-hospital mortality (26.3% vs 9.8%; p<0.001) and non-routine discharge (84.2% vs 76.9%; p=0.013), as compared with those without COVID-19. After matching, only in-hospital mortality rates remained significantly higher in patients with COVID-19 (26.7% vs 8.5%; p<0.001). Additionally, patients with COVID-19 had higher rates of thromboembolic (12.3% vs 7.6%; p=0.035) and respiratory (11.3% vs 6.6%; p=0.029) complications.
CONCLUSIONS: Among patients with MCA stroke, those with concomitant COVID-19 were significantly younger and had higher stroke severity scores. They were more likely to experience thromboembolic and respiratory complications and in-hospital mortality compared with matched controls.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
BMJ open - 14(2024), 2 vom: 27. Feb., Seite e080738 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ghaith, Abdul Karim [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 01.03.2024 Date Revised 01.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/bmjopen-2023-080738 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369078934 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369078934 | ||
003 | DE-627 | ||
005 | 20240301232813.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/bmjopen-2023-080738 |2 doi | |
028 | 5 | 2 | |a pubmed24n1313.xml |
035 | |a (DE-627)NLM369078934 | ||
035 | |a (NLM)38417967 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ghaith, Abdul Karim |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of the pandemic and concomitant COVID-19 on the management and outcomes of middle cerebral artery strokes |b a nationwide registry-based study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.03.2024 | ||
500 | |a Date Revised 01.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a OBJECTIVES: To investigate the impact of the COVID-19 pandemic as well as concomitant COVID-19 itself on stroke care, focusing on middle cerebral artery (MCA) territory infarctions | ||
520 | |a DESIGN: Registry-based study | ||
520 | |a SETTING: We used the National Inpatient Sample (NIS) database, which covers a wide range of hospitals within the USA | ||
520 | |a PARTICIPANTS: The NIS was queried for patients with MCA strokes between 2016 and 2020. In total, 35 231 patients were included | ||
520 | |a OUTCOME MEASURES: Outcome measures were postprocedural complications, length of stays (LOSs), in-hospital mortality and non-routine discharge. Propensity score matching using all available baseline variables was performed to reduce confounders when comparing patients with and without concomitant COVID-19 | ||
520 | |a RESULTS: Mechanical thrombectomy (MT) was performed in 48.4%, intravenous thrombolysis (IVT) in 38.2%, and both MT and IVT (MT+IVT) in 13.4% of patients. A gradual increase in the use of MT and an opposite decrease in the use of IVT (p<0.001) was detected during the study period. Overall, 25.0% of all patients were admitted for MCA strokes during the pandemic period (2020), of these 209 (2.4%) were concomitantly diagnosed with COVID-19. Patients with MCA strokes and concomitant COVID-19 were significantly younger (64.9 vs 70.0; p<0.001), had significantly worse NIH Stroke Severity scores, and worse outcomes in terms of LOS (12.3 vs 8.2; p<0.001), in-hospital mortality (26.3% vs 9.8%; p<0.001) and non-routine discharge (84.2% vs 76.9%; p=0.013), as compared with those without COVID-19. After matching, only in-hospital mortality rates remained significantly higher in patients with COVID-19 (26.7% vs 8.5%; p<0.001). Additionally, patients with COVID-19 had higher rates of thromboembolic (12.3% vs 7.6%; p=0.035) and respiratory (11.3% vs 6.6%; p=0.029) complications | ||
520 | |a CONCLUSIONS: Among patients with MCA stroke, those with concomitant COVID-19 were significantly younger and had higher stroke severity scores. They were more likely to experience thromboembolic and respiratory complications and in-hospital mortality compared with matched controls | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a neurology | |
650 | 4 | |a stroke | |
650 | 7 | |a Fibrinolytic Agents |2 NLM | |
700 | 1 | |a El-Hajj, Victor Gabriel |e verfasserin |4 aut | |
700 | 1 | |a Atallah, Elias |e verfasserin |4 aut | |
700 | 1 | |a Rios Zermeno, Jorge |e verfasserin |4 aut | |
700 | 1 | |a Ravindran, Krishnan |e verfasserin |4 aut | |
700 | 1 | |a Gharios, Maria |e verfasserin |4 aut | |
700 | 1 | |a Hoang, Harry |e verfasserin |4 aut | |
700 | 1 | |a Bydon, Mohamad |e verfasserin |4 aut | |
700 | 1 | |a Ohlsson, Marcus |e verfasserin |4 aut | |
700 | 1 | |a Elmi-Terander, Adrian |e verfasserin |4 aut | |
700 | 1 | |a Tawk, Rabih G |e verfasserin |4 aut | |
700 | 1 | |a Jabbour, Pascal |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMJ open |d 2012 |g 14(2024), 2 vom: 27. Feb., Seite e080738 |w (DE-627)NLM215724372 |x 2044-6055 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2024 |g number:2 |g day:27 |g month:02 |g pages:e080738 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjopen-2023-080738 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2024 |e 2 |b 27 |c 02 |h e080738 |